![]() |
Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse
Jeong Uk Lim
Tuberc Respir Dis. 2023;86(1):14-22. Published online 2022 Oct 26 DOI: https://doi.org/10.4046/trd.2022.0081
|
Citations to this article as recorded by
Factors Associated with Postoperative Recurrence in Stage I to IIIA Non–Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: Analysis of Korean National Population Data
Kyu Yean Kim, Ho Cheol Kim, Tae Jung Kim, Hong Kwan Kim, Mi Hyung Moon, Kyongmin Sarah Beck, Yang Gun Suh, Chang Hoon Song, Jin Seok Ahn, Jeong Eun Lee, Jae Hyun Jeon, Chi Young Jung, Jeong Su Cho, Yoo Duk Choi, Seung Sik Hwang, Chang Min Choi, Seung Hun
Cancer Research and Treatment.2025; 57(1): 83. CrossRef Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC
Evangelia Bogatsa, George Lazaridis, Chrysoula Stivanaki, Eleni Timotheadou
Cancers.2024; 16(9): 1619. CrossRef New targeted therapies for non-small cell lung cancer
Eun Hye Lee, Se Hyun Kwak, Chi Young Kim, Hye Ran Gwon, Eun Young Kim, Yoon Soo Chang
Journal of the Korean Medical Association.2023; 66(3): 180. CrossRef Economic burden of early-stage non-small-cell lung cancer: an assessment of healthcare resource utilization and medical costs
Jon Apple, Maral DerSarkissian, Anne Shah, Rose Chang, Yan Chen, Xuanhao He, Justin Chun
Journal of Comparative Effectiveness Research.2023;[Epub] CrossRef Perioperative immunotherapy in stage IB-III non-small cell lung cancer: a critical review of its rationale and considerations
Jae Kyeom Sim, Juwhan Choi, Sung Yong Lee
The Korean Journal of Internal Medicine.2023; 38(6): 787. CrossRef Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection
Hwa Park, Yoo Choi, Ju-Sik Yun, Sang-Yun Song, Kook-Joo Na, Joon Yoon, Chang-Seok Yoon, Hyung-Joo Oh, Young-Chul Kim, In-Jae Oh
Cancers.2023; 15(23): 5679. CrossRef
|